Caricamento...
Landiolol: pharmacology and its use for rate control in atrial fibrillation in an emergency setting
This article provides new insight on landiolol, an ultra-short acting injectable betablocker, recently approved in Europe, with regard to its pharmacokinetic and pharmacodynamic profile, along with its first experience in Caucasian healthy volunteers and patients with atrial fibrillation. Landiolol...
Salvato in:
| Pubblicato in: | Eur Heart J Suppl |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5909771/ https://ncbi.nlm.nih.gov/pubmed/30188959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/sux037 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|